Retraction: Gemcitabine aggravates miR-199a-5p-mediated breast cancer cell apoptosis by promoting VEGFA downregulation via inactivating the AKT signaling pathway

Retraction of ‘Gemcitabine aggravates miR-199a-5p-mediated breast cancer cell apoptosis by promoting VEGFA downregulation via inactivating the AKT signaling pathway’ by Dingmei Deng et al., RSC Adv., 2019, 9, 20385–20394, DOI: 10.1039/C9RA00016J.

Detalles Bibliográficos
Autor principal: Fisher, Laura
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Royal Society of Chemistry 2021
Materias:
Chemistry
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9031743/
https://www.ncbi.nlm.nih.gov/pubmed/35481960
http://dx.doi.org/10.1039/d1ra90114a
_version_ 1784692466772869120
author Fisher, Laura
author_facet Fisher, Laura
author_sort Fisher, Laura
collection PubMed
description Retraction of ‘Gemcitabine aggravates miR-199a-5p-mediated breast cancer cell apoptosis by promoting VEGFA downregulation via inactivating the AKT signaling pathway’ by Dingmei Deng et al., RSC Adv., 2019, 9, 20385–20394, DOI: 10.1039/C9RA00016J.
format Online
Article
Text
id pubmed-9031743
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher The Royal Society of Chemistry
record_format MEDLINE/PubMed
spelling pubmed-90317432022-04-26 Retraction: Gemcitabine aggravates miR-199a-5p-mediated breast cancer cell apoptosis by promoting VEGFA downregulation via inactivating the AKT signaling pathway Fisher, Laura RSC Adv Chemistry Retraction of ‘Gemcitabine aggravates miR-199a-5p-mediated breast cancer cell apoptosis by promoting VEGFA downregulation via inactivating the AKT signaling pathway’ by Dingmei Deng et al., RSC Adv., 2019, 9, 20385–20394, DOI: 10.1039/C9RA00016J. The Royal Society of Chemistry 2021-05-05 /pmc/articles/PMC9031743/ /pubmed/35481960 http://dx.doi.org/10.1039/d1ra90114a Text en This journal is © The Royal Society of Chemistry https://creativecommons.org/licenses/by/3.0/
spellingShingle Chemistry
Fisher, Laura
Retraction: Gemcitabine aggravates miR-199a-5p-mediated breast cancer cell apoptosis by promoting VEGFA downregulation via inactivating the AKT signaling pathway
title Retraction: Gemcitabine aggravates miR-199a-5p-mediated breast cancer cell apoptosis by promoting VEGFA downregulation via inactivating the AKT signaling pathway
title_full Retraction: Gemcitabine aggravates miR-199a-5p-mediated breast cancer cell apoptosis by promoting VEGFA downregulation via inactivating the AKT signaling pathway
title_fullStr Retraction: Gemcitabine aggravates miR-199a-5p-mediated breast cancer cell apoptosis by promoting VEGFA downregulation via inactivating the AKT signaling pathway
title_full_unstemmed Retraction: Gemcitabine aggravates miR-199a-5p-mediated breast cancer cell apoptosis by promoting VEGFA downregulation via inactivating the AKT signaling pathway
title_short Retraction: Gemcitabine aggravates miR-199a-5p-mediated breast cancer cell apoptosis by promoting VEGFA downregulation via inactivating the AKT signaling pathway
title_sort retraction: gemcitabine aggravates mir-199a-5p-mediated breast cancer cell apoptosis by promoting vegfa downregulation via inactivating the akt signaling pathway
topic Chemistry
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9031743/
https://www.ncbi.nlm.nih.gov/pubmed/35481960
http://dx.doi.org/10.1039/d1ra90114a
work_keys_str_mv AT fisherlaura retractiongemcitabineaggravatesmir199a5pmediatedbreastcancercellapoptosisbypromotingvegfadownregulationviainactivatingtheaktsignalingpathway

Ejemplares similares